Prices delayed by at least 15 minutes | Print


Genedrive PLC (GDR)

ORD 1.5P
Sell: 2.5p|Buy: 3.5p|Change: 0.25 (-7.69%)

Open 

3p


Previous close 

3.25p


Trade high 

3.3p


Volume 

693,527


Year high 

40.40p


Year low 

2.56p


Dividend yield 

-


Market capitalisation 

£4.15 mn


P/E ratio 

-


ISIN 

GB00B1VKB244


This share can be held in a Dealing accountISALifetime ISAJISASIPPand can be used with Dividend reinvestment

Share price

Performance 27/03/2024

1D | 1M | 3M | 1Y | 3Y ann | 5Y ann | 10Y ann


Total return (%)
Genedrive PLC+ 4.00
FTSE AIM All Share+ 0.35
More...

Company profile

Genedrive PLC is a holding company engaged in the molecular diagnostics business. It operates in one operating segment named Diagnostics which is engaged in the Genedrive Point of need molecular diagnostics platform for the diagnosis of infectious diseases and use in patient stratification (genotyping), pathogen detection, and other indications. Geographically the majority of the revenue is derived from the United Kingdom.

Sector 

Healthcare


News

Recent trades

DateTimePriceQuantityValue (£)
28/03/202408:35:39320,000600.00
28/03/202408:35:38315,000450.00
28/03/202408:28:192.986,0692,496.00
28/03/202408:28:172.917,241499.99
28/03/202408:25:082.711,36036.86

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2024 AJ Bell. All rights reserved.